These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13792446)

  • 1. A study of coagulation factors in blood and spinal fluid in multiple sclerosis.
    ALBRIGHT SD; KUPFER HG; KINNE DR
    Arch Neurol; 1959 Sep; 1():315-26. PubMed ID: 13792446
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood coagulation studies and serotonin determinations in serum and cerebrospinal fluid in multiple sclerosis.
    FELDMAN S; IZAK G; NELKEN D
    Acta Psychiatr Neurol Scand; 1957; 32(1):37-49. PubMed ID: 13434972
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of cerebrospinal fluid on blood clotting and fibrinolysis].
    Myśliwiec B
    Neurol Neurochir Pol; 1978; 12(2):161-5. PubMed ID: 149929
    [No Abstract]   [Full Text] [Related]  

  • 4. The hematologic, gastric acidity and cerebrospinal fluid findings in multiple sclerosis.
    DEKABAN AS; BRODRICK RJ; WAUGH TR
    Neurology; 1952; 2(6):514-9. PubMed ID: 13002602
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced frequency of memory CD8+ T lymphocytes in cerebrospinal fluid and blood of patients with multiple sclerosis.
    Hughes RA
    Autoimmunity; 1995; 21(4):283. PubMed ID: 8852520
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood and cerebrospinal fluid test in multiple sclerosis].
    Mori M
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():150-7. PubMed ID: 26480693
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultra-centrifuge studies of lipoproteins in multiple sclerosis.
    AIRD RB; GOFMAN JW; JONES HB; CAMPBELL B; GAROUTTE B
    Neurology; 1953 Jan; 3(1):22-34. PubMed ID: 13013495
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum and cerebrospinal fluid uric acid levels in multiple sclerosis patients.
    Zamani A; Rezaei A; Khaeir F; Hooper DC
    Clin Neurol Neurosurg; 2008 Jun; 110(6):642-3. PubMed ID: 18471958
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoelectrophoretic study of serum and cerebrospinal proteins in multiple sclerosis].
    Paltrinieri E
    Acta Neurol (Napoli); 1967; 22(2):216-27. PubMed ID: 5606826
    [No Abstract]   [Full Text] [Related]  

  • 10. [The gamma globulins of serum and of the cerebrospinal fluid in subacute sclerosing leukoencephalitis and multiple sclerosis].
    Fadiloglu M
    Acta Neurol Psychiatr Belg; 1967 Oct; 67(10):763-70. PubMed ID: 4169898
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cerebrospinal fluid proteins in multiple sclerosis].
    Dupelj M; Hamel-Puskarić N; Arko K
    Neuropsihijatrija; 1966; 14(1):51-7. PubMed ID: 5191198
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipoprotein lipase in the blood and cerebrospinal fluid of patients with multiple sclerosis].
    Kawiak W; Gieracz A; Kołodziejczyk S; Dudkowska A
    Neurol Neurochir Pol; 1977; 11(6):641-5. PubMed ID: 600344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Haptoglobin levels in the serum and the cerebrospinal fluid patients with multiple sclerosis].
    Rosnowska M; Cendrowski W
    Neurol Neurochir Pol; 1978; 12(5):579-85. PubMed ID: 724031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of certain leukocyte subpopulations in the peripheral blood and cerebrospinal fluid in multiple sclerosis].
    Czernicki J; Maciejek Z; Jurkowski A
    Neurol Neurochir Pol; 1979; 13(3):255-60. PubMed ID: 314064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated interleukin 2 levels in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
    Tomioka R; Hamaguchi K; Ohno R; Hosokawa T; Kaneko A; Tsuji T; Kurihara K
    Ann N Y Acad Sci; 1992 Apr; 650():347-50. PubMed ID: 1605493
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients.
    Caruso D; Melis M; Fenu G; Giatti S; Romano S; Grimoldi M; Crippa D; Marrosu MG; Cavaletti G; Melcangi RC
    J Neurochem; 2014 Aug; 130(4):591-7. PubMed ID: 24766130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis.
    Adachi K; Kumamoto T; Araki S
    Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis.
    Mahovic D; Petravic D; Petelin Z; Zurak N; Horvat G; Hajnsek S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):230-2. PubMed ID: 15177773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The electrophoretic demonstration of unique oligoclonal immunoglobulins in cerebrospinal fluid as a diagnostic test for multiple sclerosis.
    Casey BR; Wong ST; Mason AJ; Lee R; Ford HC
    Clin Chim Acta; 1981 Aug; 114(2-3):187-94. PubMed ID: 7285345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular treatment of chronic cerebro spinal venous insufficiency in patients with multiple sclerosis modifies circulating markers of endothelial dysfunction and coagulation activation: a prospective study.
    Napolitano M; Bruno A; Mastrangelo D; De Vizia M; Bernardo B; Rosa B; De Lucia D
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):716-20. PubMed ID: 24806325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.